We are live on ! Find out more
RCI

Ridgeback Capital Investments Portfolio holdings

AUM $80.9M
This Fund
S&P 500
This Quarter Est. Return
+44.71%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$80.9M
AUM Growth
Cap. Flow
+$44.7M
Cap. Flow %
55.26%
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
REPL icon
Replimune Group
REPL
+$44.7M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REPL icon
1
Replimune Group
REPL
$1.42B
$80.9M 100%
+7,310,656
New +$44.7M

Similar funds

Ridgeback Capital Investments's Q2 2026 Portfolio in Review

As of Q2 2026, Ridgeback Capital Investments held 1 position worth $80.9M. Its ten largest holdings account for 100% of the portfolio.

Ridgeback Capital Investments deployed $44.7M of net new capital in Q2 2026, opening 1 new position. Its largest new stake was Replimune Group: 7,310,656 shares worth $80.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Ridgeback Capital Investments's largest Q2 2026 buy was Replimune Group: 7,310,656 shares worth $80.9M.
  • Ridgeback Capital Investments's ten largest holdings make up 100% of its $80.9M portfolio in Q2 2026.
  • Ridgeback Capital Investments opened 1 new position and closed 0 in Q2 2026.

Based on Ridgeback Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.